Literature DB >> 17373355

Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria.

F P Mockenhaupt1, J P Cramer, L Hamann, M S Stegemann, J Eckert, Na-Ri Oh, R N Otchwemah, E Dietz, S Ehrhardt, N W J Schröder, U Bienzle, R R Schumann.   

Abstract

Genetic host factors play a substantial role in susceptibility to and severity of malaria, which continues to cause at least one million deaths per year. Recently, members of the toll-like receptor (TLR) family have been shown to be involved in recognition of the etiologic organism Plasmodium falciparum: The glycosylphosphatidylinisitol anchor induces signaling in host cells via TLR-2 and -4, while hemozoin-induced immune activation involves TLR-9. Binding of microbial ligands to the respective TLRs triggers the release of pro-inflammatory cytokines via the TLR/IL-1 receptor (TIR) domain and may contribute to the host response, including pro-inflammatory cytokine induction and malarial fever. In a case-control study among 870 Ghanaian children, we examined the influence of TLR-2, -4, and -9 polymorphisms in susceptibility to severe malaria. TLR-2 variants common in Caucasians and Asians were completely absent. However, we found a new, rare mutation (Leu658Pro), which impairs signaling via TLR-2. We failed to detect any polymorphisms within the TLR-9/interleukin-1 receptor domain. Two frequent TLR-9 promoter polymorphisms did not show a clear association with malaria severity. In contrast, the TLR-4-Asp299Gly variant occurred at a high rate of 17.6% in healthy controls, and was even more frequent in severe malaria patients (24.1%, p<0.05). Likewise, TLR-4-Thr399Ile was seen in 2.4% of healthy children and in 6.2% of patients (p=0.02). TLR-4-Asp299Gly and TLR-4-Thr399Ile conferred an 1.5- and 2.6-fold increased risk of severe malaria, respectively. These findings suggest TLR4-mediated responses to malaria in vivo and TLR-4 polymorphisms to be associated with disease manifestation. However some gray areas also suggest the scope for further improvements.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17373355

Source DB:  PubMed          Journal:  J Commun Dis        ISSN: 0019-5138


  39 in total

1.  Optimal CD8 T-cell response against Encephalitozoon cuniculi is mediated by Toll-like receptor 4 upregulation by dendritic cells.

Authors:  Elizabeth M Lawlor; Magali M Moretto; Imtiaz A Khan
Journal:  Infect Immun       Date:  2010-04-26       Impact factor: 3.441

2.  Toll-like receptors participate in Naegleria fowleri recognition.

Authors:  Moisés Martínez-Castillo; Leopoldo Santos-Argumedo; José Manuel Galván-Moroyoqui; Jesús Serrano-Luna; Mineko Shibayama
Journal:  Parasitol Res       Date:  2017-11-11       Impact factor: 2.289

3.  Involvement of TLR2 and TLR4 in cell responses to Rickettsia akari.

Authors:  Marco A Quevedo-Diaz; Chang Song; Yanbao Xiong; Haiyan Chen; Larry M Wahl; Suzana Radulovic; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2010-07-08       Impact factor: 4.962

4.  Malaria primes the innate immune response due to interferon-gamma induced enhancement of toll-like receptor expression and function.

Authors:  Bernardo S Franklin; Peggy Parroche; Marco Antonio Ataíde; Fanny Lauw; Catherine Ropert; Rosane B de Oliveira; Dhelio Pereira; Mauro Shugiro Tada; Paulo Nogueira; Luiz Hildebrando Pereira da Silva; Harry Bjorkbacka; Douglas T Golenbock; Ricardo T Gazzinelli
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-18       Impact factor: 11.205

5.  Polymorphisms in toll-like receptors 2, 4 and 5 are associated with Legionella pneumophila infection.

Authors:  F Zhang; X-D Gao; W-W Wu; Y Gao; Y-W Zhang; S-P Wang
Journal:  Infection       Date:  2013-03-23       Impact factor: 3.553

6.  Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes.

Authors:  D Santini; S Angeletti; A Ruzzo; G Dicuonzo; S Galluzzo; B Vincenzi; A Calvieri; F Pizzagalli; N Graziano; E Ferraro; G Lorino; A Altomare; M Magnani; F Graziano; G Tonini
Journal:  Clin Exp Immunol       Date:  2008-09-29       Impact factor: 4.330

Review 7.  The role of lipopeptidophosphoglycan in the immune response to Entamoeba histolytica.

Authors:  Isabel Wong-Baeza; Marcela Alcántara-Hernández; Ismael Mancilla-Herrera; Itzmel Ramírez-Saldívar; Lourdes Arriaga-Pizano; Eduardo Ferat-Osorio; Constantino López-Macías; Armando Isibasi
Journal:  J Biomed Biotechnol       Date:  2010-01-21

Review 8.  Role of TLRs/MyD88 in host resistance and pathogenesis during protozoan infection: lessons from malaria.

Authors:  Catherine Ropert; Bernardo S Franklin; Ricardo T Gazzinelli
Journal:  Semin Immunopathol       Date:  2007-12-11       Impact factor: 9.623

Review 9.  Functional consequences of toll-like receptor 4 polymorphisms.

Authors:  Bart Ferwerda; Matthew Bb McCall; Karlijn Verheijen; Bart-Jan Kullberg; André Jam van der Ven; Jos Wm Van der Meer; Mihai G Netea
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

10.  TLR9 polymorphisms in African populations: no association with severe malaria, but evidence of cis-variants acting on gene expression.

Authors:  Susana Campino; Julian Forton; Sarah Auburn; Andrew Fry; Mahamadou Diakite; Anna Richardson; Jeremy Hull; Muminatou Jallow; Fatou Sisay-Joof; Margaret Pinder; Malcolm E Molyneux; Terrie E Taylor; Kirk Rockett; Taane G Clark; Dominic P Kwiatkowski
Journal:  Malar J       Date:  2009-03-13       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.